Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is the Phenotype Designation by PSP-MDS Criteria Stable Throughout the Disease Course and Consistent With Tau Distribution?

2 Feb 2022

Abstract excerpt

INTRODUCTION: The MDS-PSP criteria have shown high sensitivity for the PSP diagnosis, but do not discriminate the phenotype diversity. Our purpose was to search for anatomopathological differences among PSP phenotypes resulting from the application of the MDS-PSP criteria comparing with the previous ones. METHODS: Thirty-four PSP cases from a single brain bank were retrospectively classified according to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cerebrospinal fluid and hydrocephalus
Share to Epilepsy research and treatment
Share to Neurological disorders and treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35185775
DOI: 10.3389/fneur.2022.827338

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is the Phenotype Designation by PSP-MDS Criteria Stable Throughout the Disease Course and Consistent With Tau Distribution?PMID 35185775Read ↗

Association of PSP phenotypes with survival: A brain-bank study.Semantic proximity Read ↗

Neuropathological validation of the MDS-PSP criteria with PSP and other frontotemporal lobar degenerationSemantic proximity Read ↗

Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes.Semantic proximity Read ↗

Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges.Semantic proximity Read ↗

Validation of the new pathology staging system for progressive supranuclear palsySemantic proximity Read ↗

The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.Semantic proximity Read ↗

Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?Semantic proximity Read ↗

Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.Semantic proximity Read ↗

Clinical prognostic factors in progressive supranuclear palsy: Implications for clinical trials.Semantic proximity Read ↗

Investigating differences in young- and late-onset progressive supranuclear palsy.Semantic proximity Read ↗

Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment.Semantic proximity Read ↗

The diagnosis of progressive supranuclear palsy: current opinions and challenges.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.